Stocks and Investing Stocks and Investing
Tue, March 1, 2022
Mon, February 28, 2022

Liana Moussatos Maintained (UTHR) at Buy with Decreased Target to $236 on, Feb 28th, 2022


Published on 2024-10-27 19:52:17 - WOPRAI, Liana Moussatos
  Print publication without navigation


Liana Moussatos of Wedbush, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Decreased Target from $276 to $236 on, Feb 28th, 2022.

Liana has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Julian Harrison of "BTIG" Initiated at Hold on, Friday, February 11th, 2022


This is the rating of the analyst that currently disagrees with Liana


  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Decreased Target to $203 on, Friday, February 25th, 2022

Contributing Sources